Search

everythinglearnresearchcommunity

for

Search:↓

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Targeting CXCL12 may help treat hair loss caused by androgens.

Cuscuta reflexa extracts and an isolate promoted hair growth and could be natural treatments for hair loss.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Noni fruit extract, specifically the FEA-3 sub-fraction, can increase hair growth and reduce baldness in male rabbits, potentially acting like common hair loss treatments.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Collagen networks play a key role in hair loss and follicle miniaturization.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

AMT may cause hair loss and changing dWAT activity could help treat it.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Elevated luteinizing hormone contributes to female-pattern hair loss, and blocking certain channels may help prevent it.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Engineered exosomes with EGF and FGF improve hair growth in mice with hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

DHT stops hair regrowth in mice, similar to human hair loss.

The mouse models are effective for testing new hair loss treatments.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Chemotherapy caused a woman's permanent hair loss and early menopause.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Increased PPARGC1α relates to hair thinning in common baldness.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.